Response Biomedical (V.RBM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Starowl who wrote (368)	1/8/2001 12:19:25 PM
From: Rob	Read Replies (2) of 655

Happy New Year. Regarding the rollback. Yes, unfortunately they are typically associated with desperate last ditch efforts to keep a company going. I don't believe that is the case here as I think it needs to be done to repackage the company so it is not perceived as a penny stock in Toronto. Time will tell, but the perception of 40-50 million shares in the small CDNX pond with a share price under $1.00 doesn't fly. Note that the NR indicates that the rollback is not a certainty, but apparently something managment wants to reserve the right to do if it feels it will add value. Dick and Starowl and others with whom I've corresponded over the years - I won't be posting so often, if at all, due to demands on my time.... unfortunately it also means that I'll also have to move my more speculative (fun:)), time consuming, investments into safer havens over time. My last update from management at Response indicates that recent DD by a major marketing partner went as good as could have been hoped for and that current performance on the Myoglobin test is consistent producing CV's of under 10% (significantly beating Biosite in this, and many other key performance factors). I wish they would have cut it off earlier and moved it to market more quickly instead of striving for perfection. I still believe in the technology and the operations group. I'm not so sure about the people who got us into a position of a $.25 stock. At less than a $10 million market cap, its quite an obscene bargain, once the financing is closed and if the stock is properly supported going forward. It appears that the product risk is lower than ever as well as the price - a good combination for new investors. All the best in the new year.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next